SCoTCH-seq reveals that 5-hydroxymethylcytosine encodes regulatory information across DNA strands
Abstract
In mammalian genomes, cytosine modifications form a layer of regulatory information alongside the genetic code. Decoding this information is crucial to our understanding of biology and disease. Established sequencing methods cannot simultaneously resolve cytosine’s three most common forms—cytosine (C), 5-methylcytosine (mC), and 5-hydroxymethylcytosine (hmC)—across both strands of the DNA double helix. Thus, how epigenetic information is distributed in DNA remains unclear. Here, we present S trand- Co upled T andem C ytosine H ydroxymethylation and methylation sequencing (SCoTCH-seq): an accurate and quantitative, base-resolution approach to sequence genomes, together with mC and hmC, in both strands of the same DNA fragment. We show that different forms of cytosine combine across the double helix at CpG sites to form discrete information states in the mouse epigenome. These CpG states have distinct genomic distributions—including at promoters, enhancers, and gene bodies—and have different relationships with transcription. We show that while all possible forms of hydroxymethylation occur, hmC is predominantly asymmetric and that different forms of asymmetric hmC are not equivalent. Our findings demonstrate that 5-hydroxymethylcytosine combines with different cytosine variants across the DNA double helix to form distinct states of regulatory information.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (13)
Jack S. Hardwick
Yusuf Hamied Department of Chemistry, University of Cambridge
Somdutta Dhir
Cancer Research UK Cambridge institute, University of Cambridge
Angie Kirchner
Cancer Research UK Cambridge institute, University of Cambridge
Angela Simeone
Cancer Research UK Cambridge institute, University of Cambridge
Sean M. Flynn
Cancer Research UK Cambridge institute, University of Cambridge
James M. Edgerton
Yusuf Hamied Department of Chemistry, University of Cambridge
Rafael de Cesaris Araujo Tavares
Cancer Research UK Cambridge institute, University of Cambridge
Isabel Esain-Garcia
Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA.
David Tannahill
Cancer Research UK Cambridge institute, University of Cambridge
Paula Golder
biomodal Ltd., The Trinity Building
Jack M. Monahan
biomodal Ltd., The Trinity Building
Walraj S. Gosal
biomodal Ltd., The Trinity Building
Shankar Balasubramanian
Yusuf Hamied Department of Chemistry, University of Cambridge